Stablecoin Development Corporation SDEV

Company Overview

NovaBay Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical and specialty healthcare company historically focused on developing and commercializing non-antibiotic antimicrobial products for ophthalmology, dermatology, and wound care. The company’s core competency has been the development of products based on its proprietary pure hypochlorous acid (HOCl) technology, which is designed to provide broad-spectrum antimicrobial activity while remaining well tolerated for human use.

NovaBay’s primary revenue historically came from branded, prescription, and over-the-counter healthcare products, most notably Avenova®, an eyelid and eyelash hygiene product, and NeutroPhase®, a wound care and skin cleansing solution. The company primarily served eye care professionals, hospitals, wound care clinics, and consumers through physician recommendations. NovaBay was founded in the early 2000s and evolved from a development-stage pharmaceutical company into a commercial-stage company before significantly restructuring its business through asset divestitures. Public disclosures indicate that the company’s operating focus has narrowed substantially following the sale of key product assets, materially changing its business profile.